EUVIMEDEUVIMED entdecken
Crossref

Exploring genetic associations in systemic lupus erythematosus through Mendelian randomization: implications for novel biomarkers and therapeutic targets

Qi Liu, Yuyang Liu, Hui Feng, Lin Zhao, Tao Wan

Clinical Rheumatology · 2025-01 · 44 (1) · 193-205

DOI: 10.1007/s10067-024-07094-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Rheumatology, online erschienen am 10.08.2024. Verfasst von Qi Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, 8th Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 94 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by a significant health burden. There is an essential need for novel biomarkers and therapeutic targets to improve diagnosis and management. Mendelian randomization (MR) was applied to explore causal links between SLE and various biomarkers like immune cells, metabolites, and inflammatory cytokines using multiple databases. Initially, biomarkers significantly associated with SLE were identified. Bidirectional MR helped clarify these relationships, and a two-step mediation MR examined their effects on SLE risk. Intersection analysis was used to identify biomarkers with consistent effects across datasets. Four biomarkers were identified as having significant associations with SLE risk: 1-palmitoyl-2-arachidonoyl-GPI levels [odds ratio (OR), 1.379; 95% confidence interval (CI), 1.180 to 1.613; FDR, 0.046], IL-17A levels (OR, 2.197; 95% CI, 1.412 to 3.418; FDR, 0.044), N-acetyl-aspartyl-glutamate (NAAG) levels (OR, 0.882; 95% CI, 0.831 to 0.936; FDR, 0.030), and ribitol levels (OR, 0.743; 95% CI, 0.644 to 0.857; FDR, 0.012). Bidirectional MR showed an inverse effect of NAAG on IL-17A levels (OR, 0.978; 95% CI, 0.962 to 0.994; p = 0.006). Mediation analysis indicated that NAAG influenced SLE risk both directly (beta = - 0.108) and indirectly through IL-17A (beta = - 0.018), highlighting the potential mediating role of IL-17A. After expanding the significance criteria to p 0) and 10 protective factors (beta < 0) for SLE. This research has revealed significant genetic associations with SLE and demonstrated that IL-17A mediates the relationship between NAAG levels and SLE risk, highlighting potential new targets for personalized therapeutic interventions. Key Points • This study employs MR to identify significant genetic associations between various biomarkers and SLE, providing novel insights into potential biomarkers and therapeutic targets. • Four key biomarkers were identified as significantly associated with SLE risk: 1-palmitoyl-2-arachidonoyl-GPI, IL-17A, N-acetyl-aspartyl-glutamate (NAAG), and ribitol. • The findings suggest that NAAG levels have a protective effect against SLE, partly mediated through IL-17A, indicating a complex interplay between these biomarkers in the pathogenesis of SLE. • Intersectional analysis across multiple datasets revealed 29 biomarkers with consistent effects on SLE risk, highlighting new directions for future research and potential personalized therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicHumansMendelian Randomization AnalysisBiomarkersInterleukin-17Genetic Predisposition to DiseasePolymorphism, Single Nucleotide

Stichwörter der Autor:innen

BiomarkersCytokinesGenome-wide association studyImmune systemLupus erythematosus systemicMendelian randomization analysisMetabolomics

Substanzen

BiomarkersInterleukin-17IL17A protein, human

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery, 8th Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.
  • Medical School of Chinese People's Liberation Army, Beijing, China.
  • Department of Neurosurgery, 920th Hospital of Joint Logistics Support Force, Kunming, China.
  • Department of Zhantansi Outpatient, Jingzhong Medical District of Chinese People's Liberation Army General Hospital, Beijing, China.
  • Department of Endocrinology, 8th Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.
  • Department of Hepatobiliary Surgery, 8th Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China. drwant@163.com.

Zitieren

APA

Liu, Q., Liu, Y., Feng, H., Zhao, L., & Wan, T. (2025). Exploring genetic associations in systemic lupus erythematosus through Mendelian randomization: implications for novel biomarkers and therapeutic targets. Clinical Rheumatology, 44(1), 193-205. https://doi.org/10.1007/s10067-024-07094-0

Vancouver

Liu Q, Liu Y, Feng H, Zhao L, Wan T. Exploring genetic associations in systemic lupus erythematosus through Mendelian randomization: implications for novel biomarkers and therapeutic targets. Clinical Rheumatology. 2025;44(1):193-205. doi:10.1007/s10067-024-07094-0

BibTeX
@article{Liu2025,
  author = {Liu, Qi and Liu, Yuyang and Feng, Hui and Zhao, Lin and Wan, Tao},
  title = {Exploring genetic associations in systemic lupus erythematosus through Mendelian randomization: implications for novel biomarkers and therapeutic targets},
  journal = {Clinical Rheumatology},
  year = {2025},
  volume = {44},
  number = {1},
  pages = {193--205},
  doi = {10.1007/s10067-024-07094-0}
}
Kostenlos starten →